These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 20155475
1. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics. Antoon JW, Liu J, Ponnapakkam AP, Gestaut MM, Foroozesh M, Beckman BS. Cancer Chemother Pharmacol; 2010 May; 65(6):1191-5. PubMed ID: 20155475 [Abstract] [Full Text] [Related]
2. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. Antoon JW, Liu J, Gestaut MM, Burow ME, Beckman BS, Foroozesh M. J Med Chem; 2009 Sep 24; 52(18):5748-52. PubMed ID: 19694470 [Abstract] [Full Text] [Related]
4. Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides. Liu J, Antoon JW, Ponnapakkam A, Beckman BS, Foroozesh M. Bioorg Med Chem; 2010 Jul 15; 18(14):5316-22. PubMed ID: 20639111 [Abstract] [Full Text] [Related]
5. Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer. Antoon JW, Beckman BS. Bioorg Med Chem Lett; 2012 Apr 01; 22(7):2624-8. PubMed ID: 22366655 [Abstract] [Full Text] [Related]
6. Design, synthesis and biological activity of cell-penetrating peptide-modified octreotide analogs. Xie W, Liu J, Qiu M, Yuan J, Xu A. J Pept Sci; 2010 Feb 01; 16(2):105-9. PubMed ID: 20014325 [Abstract] [Full Text] [Related]
7. Anticancer activity of a ceramide analog containing a disulfide linkage. Bittman R, Li Z, Samadder P, Arthur G. Cancer Lett; 2007 Jun 18; 251(1):53-8. PubMed ID: 17141948 [Abstract] [Full Text] [Related]
8. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells. Akbas SH, Timur M, Ozben T. J Surg Res; 2005 May 01; 125(1):49-55. PubMed ID: 15836850 [Abstract] [Full Text] [Related]
9. Tailoring structure-function and targeting properties of ceramides by site-specific cationization. Szulc ZM, Bielawski J, Gracz H, Gustilo M, Mayroo N, Hannun YA, Obeid LM, Bielawska A. Bioorg Med Chem; 2006 Nov 01; 14(21):7083-104. PubMed ID: 16919460 [Abstract] [Full Text] [Related]
10. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells. Crawford KW, Bittman R, Chun J, Byun HS, Bowen WD. Cell Mol Biol (Noisy-le-grand); 2003 Nov 01; 49(7):1017-23. PubMed ID: 14682383 [Abstract] [Full Text] [Related]
11. Bombesin analogs containing alpha-amino-isobutyric acid with potent anticancer activity. Prasad S, Mathur A, Gupta N, Jaggi M, Singh AT, Rajendran P, Sanna VK, Datta K, Mukherjee R. J Pept Sci; 2007 Jan 01; 13(1):54-62. PubMed ID: 17031871 [Abstract] [Full Text] [Related]
12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 Jan 01; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
13. Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells. Simoni D, Rizzi M, Rondanin R, Baruchello R, Marchetti P, Invidiata FP, Labbozzetta M, Poma P, Carina V, Notarbartolo M, Alaimo A, D'Alessandro N. Bioorg Med Chem Lett; 2008 Jan 15; 18(2):845-9. PubMed ID: 18039573 [Abstract] [Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
15. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells. Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY. Breast Cancer Res Treat; 2010 Jan 15; 119(2):255-69. PubMed ID: 19221875 [Abstract] [Full Text] [Related]
16. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB. Cancer Res; 1996 Dec 01; 56(23):5319-24. PubMed ID: 8968076 [Abstract] [Full Text] [Related]
17. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA, Di X, Walker TD, Sawyer ST. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [Abstract] [Full Text] [Related]
18. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. Ponnapakam AP, Liu J, Bhinge KN, Drew BA, Wang TL, Antoon JW, Nguyen TT, Dupart PS, Wang Y, Zhao M, Liu YY, Foroozesh M, Beckman BS. Bioorg Med Chem; 2014 Feb 15; 22(4):1412-20. PubMed ID: 24457089 [Abstract] [Full Text] [Related]
19. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP. Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668 [Abstract] [Full Text] [Related]
20. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. Chintalapati M, Truax R, Stout R, Portier R, Losso JN. J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]